Quantitative pancreatic MRI for diabetes: current state and future promise

Quantitative pancreatic MRI shows promise as a non-invasive biomarker for evaluating diabetic pathophysiology, early diagnosis, and monitoring therapy. Integration of AI and radiomics is preliminary, requiring multi-center validation before clinical use.

• Current diabetes diagnosis relies on blood glucose and symptoms; quantitative MRI can visualize pancreatic pathophysiological alterations.
• Integration of AI and radiomics enables automated high-throughput analysis, but clinical translation remains preliminary.
• Critical gaps include the need for multi-center external validation and standardized models before reliable clinical use.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.